Skip to content
Abierto
Menu

Award notice

Anti-Mouse INFAR-1 MAR1-5A3 mAb

HT9425-24-D-0009

Defense Health Agency (Dha), Army Med Res Acq Activity. In-Vitro Diagnostic Substance Manufacturing.

View on SAM.govMarkdown

Awarded

Leinco Technologies, Inc.

$650,000.00 on the award notice, August 23, 2024, contract HT9425-24-D-0009

Description

As published on SAM.gov.

Leinco Technologies, Inc. recieved a Firm Fixed Price Sole Source IDIQ award for the delivery of Anti- Mouse IFNAR-1 MAR1-5A3; PLATINUM functional grade antibody in support of United States Army Medical Research Institute of Infectious Diseases (USAMRIID).

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Leinco Technologies, Inc.
UEI
G7GHZKCJWDE3
CAGE
5AHK0
Vendor location
Fenton, MO
Contract
HT942524D0009
Obligated
$0.00, potential $1,300,000
Actions
5 between August 23, 2024 and February 9, 2026
Competition
Not Competed Under SAP, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Materiel Requirement for the Delivery of Monoclonal Antibodies.
Match
award number HT942524D0009 equals the contract number; same awarding office HT9425 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. August 23, 2024

    Award notice

    Anti-Mouse INFNAR-1 MAR1-5A3 mAb

    Awarded to LEINCO TECHNOLOGIES, Inc. Fenton for $650,000. SAM.gov, notice 067152b55e704c3e9c33adc7b5b27c49

  2. August 23, 2024

    Award notice

    Awarded to LEINCO TECHNOLOGIES, Inc. Fenton for $650,000. SAM.gov, notice 791256934c1549ecb9f7b7357ab69348

Points of contact

Also open from this buyer